Sa1522 EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY

2020 ◽  
Vol 158 (6) ◽  
pp. S-1319-S-1320
Author(s):  
Ho Bae ◽  
Huy N. Trinh ◽  
Harry L. Janssen ◽  
Claire Fournier ◽  
Wan-Long Chuang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Renal Impairment ◽  
Chronic Hepatitis B ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Tenofovir Alafenamide

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

Hepatology ◽  
2011 ◽  
Vol 54 (1) ◽  
pp. 91-100 ◽  
Author(s):  
Yun-Fan Liaw ◽  
Maria Raptopoulou-Gigi ◽  
Hugo Cheinquer ◽  
Shiv Kumar Sarin ◽  
Tawesak Tanwandee ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Efficacy And Safety ◽  
Hepatic Decompensation ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document